Previous 10 | Next 10 |
Lucid Diagnostics Launches First EsoGuard® Mobile Test Unit PR Newswire First esophageal precancer detection event utilizing an EsoGuard mobile test unit to be hosted today by Florida Digestive Health Specialists in Sarasota, Florida NEW YORK , June 5, 2...
PAVmed Digital Health Subsidiary, Veris Health, Joins Cancer Moonshot's CancerX Partnership as Founding Member PR Newswire NEW YORK , June 2, 2023 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) ("PAVmed"), a diversified commercial-stage medical te...
2023-05-24 08:00:21 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Developing groundbreaking drugs and devices entails high costs, uncertain regulatory approval, and lucrative revenues. Those factors and more culminate to create a sector filled with dozens of ...
2023-05-17 11:00:24 ET PAVmed Inc. (PAVM) Q1 2023 Earnings Conference Call May 17, 2023 8:30 am ET Company Participants Lishan Aklog - Chairman, Chief Executive Officer Dennis McGrath - Executive Vice President, Chief Financial Officer Michael Parks - Vice Presid...
2023-05-17 02:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-05-16 17:07:41 ET PAVmed press release ( NASDAQ: PAVM ): Q1 Non-GAAP EPS of -$0.10 beats by $0.07 . Revenue of $0.45M (+136.8% Y/Y) beats by $0.22M . PAVmed had cash and cash equivalents of $49.3 million as of March 31, 2023, compared to $39.7 million as o...
PAVmed Provides Business Update and First Quarter Financial Results PR Newswire EsoGuard ® test volume gains momentum as Lucid expands high-volume testing events PAVmed appoints President for Veris Health and expands commercial footprint Conference cal...
Lucid Diagnostics Provides Business Update and First Quarter Financial Results PR Newswire EsoGuard ® test volume increases 57 percent sequentially and 245 percent year-on-year Conference call and webcast to be held tomorrow, May 16 th at 8:30 AM EST...
2023-05-12 15:00:44 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...
Lucid Diagnostics and Collaborators Present New EsoGuard® and EsoCheck® Data at Digestive Disease Week® (DDW) 2023 Conference PR Newswire EsoGuard ® continues to demonstrate excellent esophageal precancer and cancer detection performance, including in m...
News, Short Squeeze, Breakout and More Instantly...
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire Quarterly EsoGuard ® test volume increased 31 percent sequentially NEW YORK , July 23, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("L...
Lucid Diagnostics Launches New Corporate Website PR Newswire NEW YORK , July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-ow...
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population PR Newswire Prospective screening study demonstrates excellent EsoGuard s...